Back to Nuveen, LLC Nuveen, LLC

KROSKROS
6 quarters

Position history for Nuveen, LLCNuveen, LLC's holdings in KEROS THERAPEUTICS INC

Nuveen, LLC holds 247,756 shares of KROS (KEROS THERAPEUTICS INC), worth $2.7M as of 2026-Q2. The position was decreased (-5.5% shares). KROS represents 0.0% of Nuveen, LLC's portfolio.

Current Value

$2.7M

Current Shares

247,756

Total Value Change

-$91.9M

Total Shares Change

-3.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
247,756
-5.5%
$2.7M0.0%$10.70
0
2026-Q1
Increased
262,075
+315.4%
$2.9M0.0%$13.40
42
2025-Q4
Decreased
63,097
-16.8%
$1.3M0.0%$20.27
0
2025-Q3
Unchanged
75,855
0.0%
$1.2M0.0%$15.95
0
2025-Q2
Decreased
75,855
-98.1%
$1M0.0%$13.49
0
2025-Q1
New
3.9M
-
$94.5M0.0%$10.79
41

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used